Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial

Sexual dysfunction commonly occurs with major depressive disorder (MDD). Vilazodone, a selective serotonin reuptake inhibitor and 5-HT(1A) receptor partial agonist antidepressant approved for the treatment of MDD in adults, was evaluated to determine its effects on sexual function. The primary study...

Descripción completa

Detalles Bibliográficos
Autores principales: Clayton, Anita H., Gommoll, Carl, Chen, Dalei, Nunez, Rene, Mathews, Maju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457500/
https://www.ncbi.nlm.nih.gov/pubmed/26039688
http://dx.doi.org/10.1097/YIC.0000000000000075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457500/
https://www.ncbi.nlm.nih.gov/pubmed/26039688
http://dx.doi.org/10.1097/YIC.0000000000000075

Ejemplares similares